In a preclinical model of liver fibrosis, targeted delivery of HSP47 siRNA by AA-T3A-C12 LNP led to ~65% silencing of HSP47, which outperformed the benchmark MC3 LNP by two-fold. Here, SERPINH1 is linked to Hepatic fibrosis.